Cipla Limited (LUX:CIPLA)

Market Cap	9.18B -26.7%
Revenue (ttm)	2.65B +4.7%
Net Income	430.93M -8.9%
EPS	0.53 -8.9%
Shares Out	n/a
PE Ratio	21.31
Forward PE	22.56
Dividend	0.12 (0.94%)
Ex-Dividend Date	Jun 26, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	13.30
Day's Range	n/a
52-Week Range	13.00 - 18.90
Beta	n/a
RSI	29.40
Earnings Date	May 11, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Pharmaceutical Preparations
• Founded: 1935
• Employees: 30,313
• Stock Exchange: Luxembourg Stock Exchange
• Ticker Symbol: CIPLA

Financial Performance

In fiscal year 2025, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.

Financial numbers in INR